| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 6.9e-05 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -6.8e-05 | 1 |